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 2 
Abstract 22 
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) has a narrow host cell 23 
tropism, limited to cells of the monocyte/macrophage lineage. CD163 protein is expressed at 24 
high levels on the surface of specific macrophage types and a soluble form is circulating in 25 
blood. CD163 has been described as a fusion receptor for PRRSV, with the scavenger receptor 26 
cysteine-rich domain 5 (SRCR5) region having been shown to be the interaction site for the 27 
virus. 28 
As reported earlier, we have generated pigs in which Exon 7 of the CD163 gene has been 29 
deleted using CRISPR/Cas9 editing in pig zygotes. These pigs express CD163 protein lacking 30 
SRCR5 (ΔSRCR5 CD163) and show no adverse effects when maintained under standard 31 
husbandry conditions. The ΔSRCR5 CD163 was not only detected on the surface of 32 
macrophage subsets, but the secreted, soluble protein can also detected in the serum of the 33 
edited pigs, as shown here by porcine soluble CD163-specific ELISA. Previous results showed 34 
that primary macrophage cells from ΔSRCR5 CD163 animals are resistant to PRRSV-1, 35 
subtypes 1, 2, and 3, as well as PRRSV-2 infection in vitro. Here, ΔSRCR5 pigs were challenged 36 
with a highly virulent PRRSV-1, subtype 2 strain. In contrast to the wildtype control group, 37 
ΔSRCR5 pigs showed no signs of infection and no viremia or antibody response indicative of a 38 
productive infection. Histopathological analysis of lung and lymph node tissue showed no 39 
presence of virus replicating cells in either tissue. This shows that ΔSRCR5 pigs are fully 40 
resistant to infection by the virus.    41 
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 3 
Importance  42 
Porcine Reproductive and Respiratory Syndrome virus (PRRSV) is the etiological agent of 43 
PRRS, causing late-term abortions, stillbirths, and respiratory disease in pigs, incurring major 44 
economic losses to the world-wide pig industry. The virus is highly mutagenic and can be 45 
divided into two species, PRRSV-1 and PRRSV-2, each containing several subtypes. Current 46 
control strategies mainly involve biosecurity measures, depopulation, and vaccination. 47 
Vaccines are at best only partially protective against infection with heterologous subtypes and 48 
sublineages and modified-live vaccines have frequently been reported to revert to virulence. 49 
Here we demonstrate that a genetic control approach results in complete resistance to PRRSV 50 
infection in vivo. CD163 is edited such as to remove the viral interaction domain while 51 
maintaining protein expression and biological function, averting any potential adverse effect 52 
associated with protein knock-out. This research demonstrates a genetic control approach 53 
with potential benefits in animal welfare as well as to the pork industry.   54 
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 4 
Introduction 55 
Porcine reproductive and respiratory syndrome (PRRS) is arguably the most economically 56 
important infectious diseases affecting pigs worldwide. The causative agent of PRRS is PRRS 57 
virus (PRRSV), a member of the Arteriviridae family and the order Nidovirales. Infected pigs of 58 
all ages may present with symptoms involving inappetence, fever, lethargy, and respiratory 59 
distress. However, the most devastating effects of PRRSV infection are observed in young 60 
piglets and pregnant sows. In pregnant sows full abortions or death and mummification of 61 
fetuses in utero are observed and live-born piglets from an antenatal infection are often weak 62 
and display severe respiratory symptoms (1-3). Piglets infected with PRRSV in early life can 63 
show diarrhea and more commonly severe respiratory distress due to active PRRSV 64 
replication in pulmonary macrophages and subsequent damage in lung tissues (4). Due to 65 
reduction or loss of pregnancies, death in young piglets, and decreased growth rates in all 66 
PRRSV infected pigs it is estimated that the economic impact of PRRSV to pork producers in 67 
the United States alone is more than $650m annually (5, 6). 68 
There are two different species of PRRSV with distinct geographic distributions, PRRSV-1 is 69 
found primarily in Europe and Asia, overlapping the range of PRRSV-2, which is found in Asia 70 
and the Americas. PRRSV-1 can be further divided into at least three subtypes, currently based 71 
on ORF7 sequences and geographical distribution, with subtype 1 being pan-European whilst 72 
subtypes 2 and 3 are currently limited to Eastern Europe (7). 73 
PRRSV has a very narrow host cell range, infecting only specific subsets of porcine 74 
macrophages (8-10). Entry of PRRSV into macrophages has been shown to occur via pH-75 
dependent, receptor mediated endocytosis (11, 12). Various attachment factors and receptors 76 
have been indicated to be involved in the PRRSV entry process (reviewed in (13)). However, 77 
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 5 
only the scavenger receptor CD163, also known as a hemoglobin/haptoglobin scavenger 78 
receptor or p155, has been confirmed to be an essential fusion receptor in vitro and in vivo 79 
(14-16). CD163 is expressed on specific subtypes of macrophages. The extracellular portion of 80 
CD163 forms a pearl-on-a-string structure of nine scavenger receptor cysteine-rich (SRCR) 81 
domains and is anchored by a single transmembrane segment and a short cytoplasmic domain 82 
(17). A proteolytically cleaved, soluble form of the protein ectodomain is found in the blood 83 
stream, and is involved in the inflammation and ischemic repair response (18, 19). 84 
Transmembrane anchoring and interaction with the SRCR domain 5 (SRCR5) of CD163 were 85 
found to be essential for successful infection with PRRSV (20, 21). CD163 has a variety of 86 
biological functions, including mediating systemic inflammation and the removal of 87 
hemoglobin from blood plasma (reviewed in (21, 22)). Overexpression of CD163 renders non-88 
susceptible cells permissive to PRRSV infection (20), and it was found that CD163 does not 89 
mediate internalization but is crucial for fusion (16).  90 
Recent in vivo challenge experiments of pigs in which both copies of the CD163 gene had been 91 
knocked-out using gene editing technology confirmed that CD163 is required for infection by 92 
PRRSV-2 and highly pathogenic PRRSV-2 (HP-PRRSV) (14, 23). Gene editing technology has 93 
also been used to generate pigs in which the CD163 SRCR5 encoding sequence has been 94 
replaced with a sequence encoding human CD163L1 domain SRCR8  (24), and in effect 95 
replicating in vivo the earlier in vitro domain swapping experiment of Van Gorp and colleagues 96 
(25). This attempt to maintain CD163 function rendered pigs and macrophages resistant to 97 
PRRSV-1 but not PRRSV-2 infection (24), making this strategy ineffective in combating both 98 
PRRSV species. CD163 has important biological functions and the complete knockout could 99 
have a negative physiological impact on the animal, particularly with respect to inflammation 100 
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 6 
response and/or infection by other pathogens. Interestingly, whereas all the other eight SRCR 101 
domains have been shown to be involved in different biological functions, no specific role has 102 
been associated with SRCR5, other than in PRRSV infection (21). Therefore, we generated pigs 103 
lacking SRCR5 by deletion of exon 7 of CD163 using CRISPR/Cas9 editing and showed that 104 
macrophages from these pigs were resistant to both PRRSV-1 and PRRSV-2 infection in vitro 105 
(15). The aim of the experiments described here was to determine whether our in vitro results 106 
would translate directly in vivo by conducting a PRRSV challenge of pigs with a CD163 SRCR5 107 
deletion. Further, we aimed to characterize the biological function of the modified CD163 108 
protein (ΔSRCR5 CD163) both as a soluble and a cell-bound protein.   109 
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 7 
Results 110 
Genome editing in zygotes for ΔSRCR5 CD163 pigs and breeding genotypically uniform F2 pigs 111 
Founder generation F0 animals carrying a deletion of exon 7 in the CD163 gene, which 112 
encodes SRCR5 of the protein, were generated by CRISPR/Cas9 gene editing as previously 113 
described (ΔSRCR5 pigs, (15)). Briefly, zygotes were microinjected with a combination of 114 
Cas9mRNA and guide RNAs targeting sites flanking exon 7, resulting in double-strand breaks 115 
(DSBs) and deletion of the exon (Figure 1A). Cross-breeding of heterozygous founder animals 116 
and outbreeding with wildtype pigs yielded a first generation composed of both heterozygous 117 
and biallelic edited animals (F1 generation, (15)). We selected for breeding heterozygous F1 118 
animals displaying a “clean” deletion between the DSBs, i.e. no ‘on-target’ sequence changes 119 
beyond the desired deletion region. To generate a cohort with comparable genetic background 120 
half sibling heterozygous animals and wildtype animals were bred to yield homozygous 121 
ΔSRCR5 animals (Figure 1A) and wildtype half and full sibling animals. 122 
As previously described, ΔSRCR5 animals express the ΔSRCR5 CD163 mRNA and protein at 123 
equivalent levels to CD163 transcripts and protein in wildtype siblings. Furthermore, the 124 
native-structure ΔSRCR5 CD163 is recognized on the surface of pulmonary alveolar 125 
macrophages (PAMs) by a commercial antibody (15). We further analyzed whether a 126 
template-based protein structure analysis by RaptorX predicted folding of each subdomains 127 
compatible with a functional ΔSRCR5 CD163 protein (26). As demonstrated in figure 1B, all 128 
subdomains in both the full-length and ΔSRCR5 CD163 are predicted to adopt the globular 129 
structure and retain the pearl-on-a-string configuration of the native CD163 protein. This 130 
supports our findings indicating proper folding and expression of the ΔSRCR5 protein. 131 
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 8 
Previously, we have shown that PAMs and in vitro differentiated peripheral blood monocytes 132 
are resistant to infection with both PRRSV-1 and PRRSV-2. Now, we aimed to assess the 133 
resistance of these pigs to PRRSV-1 infection in vivo. We selected four homozygous ΔSRCR5 F2 134 
animals and four wildtype controls that were co-housed from weaning (Figure 1C). Blood 135 
samples were taken from all eight pigs and a full blood count conducted by the diagnostics 136 
laboratory at the Royal (Dick) School of Veterinary Sciences, University of Edinburgh. The 137 
blood counts of all animals were within reference values indicating good general health and 138 
the absence of infection or inflammation. Furthermore, the hemoglobin levels of all animals 139 
were within reference values, indicating normal function of the hemoglobin/haptoglobin 140 
scavenging activity of CD163 (Table 1). 141 
At 6 weeks of age a serum sample was collected from all animals prior to movement to a 142 
specified pathogen-free (SPF) unit. The cohort were co-housed for the duration of the 143 
experiment and allowed to settle for one week prior to initiation of the challenge. On day 0 of 144 
the challenge with PRRSV-1 a second serum sample was taken and soluble CD163 (sCD163) 145 
serum levels were assessed using a commercially available enzyme-linked immunosorbent 146 
assay (ELISA) recognizing soluble porcine CD163. Serum CD163 levels were found to be 147 
433.2±69.57 ng/ml in wildtype pigs and 463.5 ±68.99 ng/ml in ΔSRCR5 pigs (Figure 2). These 148 
results are not significantly different from each other (P=0.7512) and are comparable to 149 
sCD163 levels in humans (for example (27)). 150 
ΔSRCR5 pigs are resistant to PRRSV-1 infection 151 
At 7-8 weeks of age the pigs were inoculated intranasally with the PRRSV-1, subtype 2 strain 152 
BOR-57 (28). Eastern European strains are often associated with higher pathogenicity than 153 
other PRRSV-1. For BOR-57, we previously observed mild respiratory symptoms, elevated 154 
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 9 
core temperature, extensive lung pathology, and high viral loads in serum. For this study, the 155 
strain was selected due to the high viremia and shedding levels expected to occur under study 156 
conditions. The experiment was conducted for a period of 14 days following inoculation of 157 
each pig on days 0 and 1 with 5E6 TCID50, as determined by assessment on PAMs, of the virus 158 
isolate used. Rectal temperature, respiration, nasal discharge, coughing, and demeanor were 159 
recorded every day and serum samples were collected on days 0 (prior to challenge), 3, 7, 10, 160 
and 14 (prior to euthanasia). Weights were recorded on day 0, 7, and 14 (prior to euthanasia). 161 
People assessing the pigs clinically, conducting the challenge, and analyzing the pathology 162 
were blinded to the genotype status of the animals.  163 
The rectal temperatures were significantly elevated on days 6-9 of the challenge in the 164 
wildtype animals, whereas no fever was observed in the SRCR5 animals (Figure 3A). The 165 
average daily weight gain of the SRCR5 pigs was higher compared to their wildtype 166 
counterparts over the entire challenge period and significantly higher over days 7-14 167 
(p=0.0465, Figure 3B). One wildtype pig showed decreased demeanor on days 7-8, no 168 
respiratory symptoms or other abnormalities in behavior were observed in any of the other 169 
animals during the course of the study, as expected in a PRRSV-1 infection at this age. Viral 170 
RNA was isolated from serum and virus levels quantified using a DNA fragment template 171 
standard and viral RNA extracted from virus stocks of known infectivity. Whereas the wildtype 172 
pigs showed a high viremia no viral RNA was detected in the serum of SRCR5 pigs (Figure 173 
3C). The presence of antibodies against PRRSV was assessed using a commercial ELISA able to 174 
detect antibodies against all PRRSV-1 subtypes and PRRSV-2. PRRSV antibodies were detected 175 
in wildtype pigs from day 7 and present at significant levels (as per the manufacturers 176 
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 10 
indicated positive threshold >0.4 s/p ratio) on days 10 and 14 (Figure 3D), but were not 177 
detected in samples from the SRCR5 pigs collected during the course of the experiment. 178 
During necropsy lungs were assessed initially and detailed photographs taken of the dorsal 179 
and ventral side. Lungs were scored for the presence of lesions. An established scoring system, 180 
based on the approximate contribution of each lung section to the complete lung volume was 181 
employed (29). On average, 61% of the lung surface of control pigs was found to be mottled-182 
tan with areas of consolidations compared to 0.25% of lung surfaces in SRCR5 pigs (Figure 3 183 
E & G). Samples of the lungs were fixed in formalin, embedded in paraffin, cut into sections, 184 
and stained for further analysis. To assess general lung histology samples were stained with 185 
hematoxylin and eosin. Sections from each pig were assessed for the presence of interstitial 186 
pneumonia on a scale of 0-6 (0, normal; 1, mild multifocal; 2, mild diffuse; 3, moderate 187 
multifocal; 4, moderate diffuse; 5, severe multifocal; 6, severe diffuse). Microscopic lung 188 
lesions characterized by multifocal to diffuse interstitial pneumonia with type 2 pneumocytes, 189 
hypertrophy, and hyperplasia were only observed in wildtype animals (averaged 4) and were 190 
not present in lung sections of SRCR5 pigs (Figure 3 E & F, top). The presence of PRRSV 191 
antigens was assessed by immunohistochemistry on lung sections and lymph node sections 192 
using a mixture of two different antibodies against the PRRSV-N protein as described before 193 
(30). PRRSV antigens were detected in 3 out of 4 lung sections and 1 out of 4 lymph node 194 
sections of wildtype animals, but no PRRSV antigens were detected in sections from SRCR5 195 
pigs (Figure 3 E & F, bottom).  196 
Overall, no signs of infection were detected in SRCR5 animals despite the high initial 197 
inoculation volume and persistent exposure to infected wildtype animals that actively shed 198 
virus (the wildtype and edited pigs were co-housed throughout the experiment). This is a clear 199 
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 11 
demonstration that SRCR5 animals are resistant to PRRSV-1 infection, confirming our 200 
previous in vitro results (15). 201 
SRCR5 pigs show no cytokine response to PRRSV-1 infection and generally normal cytokine 202 
levels 203 
CD163 is involved in the cytokine response to infection and immune stimuli, as well as 204 
hemoglobin-haptoglobin (Hb-Hp) uptake. Hb-Hp stimulation has been shown to lead to 205 
increased levels of IL-6 and IL-10 as well as IL-1 and TNFα downregulation (31, 32). SRCR 206 
domains 1-4 and 6-9 contain binding sites for TNF-like weak inducer of apoptosis (TWEAK), 207 
an anti-inflammatory cytokine that negatively regulates CD163 expression (33, 34). 208 
Stimulation with inflammatory mediators can induce secretion of soluble CD163 and TNFα in 209 
an ADAM17-mediated manner (35). In order to assess these biological functions in the  210 
SRCR5 pigs we assayed expression levels of key cytokines. Quantitative antibody arrays were 211 
used to assess the expression levels of 20 cytokines in serum collected from pigs on day 0 212 
(prior to challenge), 3, 7, 10, and 14 of the challenge. Overall, baseline cytokine levels as 213 
determined on day 0, considered a baseline were similar between ΔSRCR5 and wildtype pigs. 214 
However, the monokine induced by gamma interferon (MIG, also known as CXCL9) was found 215 
to show consistently higher levels in wildtype pigs until day 10, after which no significant 216 
difference was detected. MIG is a T-cell chemoattractant to inflammation sites and involved in 217 
repair of tissue damage. In wildtype animals MIG was strongly upregulated on days 7 and 10 218 
of the challenge (36) (Figure 4H). The chemokine ligand 3-like 1 (CCL3L1, an isoform of MIP-219 
1α), involved in the inflammation response via CCR5 signaling and downregulated by IL-10 220 
(37), was found to be higher in wildtype compared to ΔSRCR5 animals (Figure 4J). As IL-10 221 
levels were found to be comparable in both genotype groups IL-10-mediated downregulation 222 
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 12 
is unlikely to be the cause of low CCL3L1 levels. In wildtype animals CCL3L1 was elevated in 223 
the serum on days 10 and 14, whereas no significant IL-10 elevation was found to occur over 224 
the period of the challenge (Figure 4O). 225 
We observed sequential cytokine responses to PRRSV-1 infection in wildtype animals, with an 226 
early increase in interferon α (IFNα), interleukin-17A (IL-17A), and the IL 1 receptor 227 
antagonist (IL-1ra) (Figure 4A, B, and C), followed by an increase in ILs 4, 6, and 8 (IL-4, IL-6, 228 
and IL-8, respectively) at the high point of viremia, from 7days post inoculation (dpi) (Figure 4 229 
D, E, and F). Increased levels of MIG, and the macrophage inflammatory protein 1β (MIP-1β, 230 
also known as CCL4) were only observed transiently at 10 dpi (Figure 4 G and H). In the last 231 
period of the challenge, with moderate but reducing levels of viremia, elevations in CCL3L1, 232 
granulocyte macrophage colony stimulating factor (GM-CSF), ILs 12 and 1β (IL-12 and IL-1β) 233 
were detected (Figure 4 I, J, K, L, and M). All of these cytokine responses were restricted to 234 
wildtype animals, with no cytokine response recorded in ΔSRCR5 pigs. IL-10, transforming 235 
growth factor β1 (TGFβ1), and IFN γ (IFNγ) levels showed no significant difference between 236 
wildtype and ΔSRCR5 pigs at any of the time points but were found to change significantly 237 
over time in the wildtype animals (calculated using a two-way ANOVA & Sidak’s multiple 238 
comparison test) (Figure 4 N, O, P). IL 18 (IL-18) levels decreased significantly over time in 239 
wildtype animals but were not significantly different from those of ΔSRCR5 pigs at each time 240 
point (Figure 4 Q). Platelet endothelial cell adhesion molecule (PECAM1) was significantly 241 
elevated on day 3 of the challenge and decreased on day 10 compared to levels of ΔSRCR5 pigs 242 
(Figure 4 R). No significant difference in levels of IL 1α (IL-1α) and IL 13 (IL-13) was found 243 
between ΔSRCR5 and wildtype pigs or over time (Figure 4 S and T).  244 
 o
n
 June 25, 2018 by UNIVERSITY O
F EDINBURG
H
http://jvi.asm.org/
D
ow
nloaded from
 
 13 
Discussion 245 
The results of this study show that ΔSRCR5 pigs are healthy under standard husbandry 246 
conditions and maintain biological function of the CD163 protein, whilst being resistant to 247 
PRRSV infection. So far, we have bred three generations of edited animals with over 10 litters 248 
and didn’t observe any abnormalities in breeding.  249 
ΔSRCR5 pigs were generated, as previously described (15), by using two sgRNAs flanking exon 250 
7 of CD163 CRISPR/Cas9. Here we have shown that heterozygous and homozygous animals 251 
can be bred naturally and yield normal litter size offspring. Our previous data showed that 252 
primary PAMs and peripheral blood monocyte (PBMC)-derived macrophages from ΔSRCR5 253 
pigs are fully resistant to PRRSV-1, subtype 1, 2, and 3 infection as well as to both typical and 254 
atypical PRRSV-2 (15). To confirm that these results translated to the in vivo model we showed 255 
here that ΔSRCR5 pigs are completely resistant to infection with a highly virulent PRRSV-1, 256 
subtype 2 strain. The edited animals displayed no clinical or pathological signs of infection, no 257 
viral replication was observed, and no cytokine response (indicative of low level virus 258 
replication) was observed. This confirms that our previous in vitro results directly translate to 259 
the in vivo situation. 260 
The ΔSRCR5 CD163 protein was previously detected on the surface of CD163-expressing 261 
macrophages using a native-confirmation antibody (15). Analysis of the ΔSRCR5 CD163 amino 262 
acid sequence in silico using RaptorX predicts that post-translational folding will yield a 263 
protein that closely mimics the structure of full length CD163. The expression of ΔSRCR5 264 
CD163 in animals has several advantages over previously described PRRSV-resistant CD163 265 
knockout animals generated by the random introduction of a premature stop codon in exon 3 266 
or exon 7 of the CD163 gene (14, 23). Free hemoglobin, often released following hemolytic 267 
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 14 
events, can cause serious toxicity to a system (reviewed in (38)). CD163 is a direct mediator of 268 
the Hb-Hp complex uptake into macrophages, which sequesters and degrades this potentially 269 
toxic compound (39). We have previously shown that PBMC-derived macrophages from 270 
ΔSRCR5 animals are still capable of CD163-mediated Hb-Hp uptake, as demonstrated by HO-1 271 
upregulation and uptake of fluorescently labelled HbAF488-Hp complex (15). All ΔSRCR5 272 
animals show normal hemoglobin levels in their blood, confirming the proper clearance of Hb-273 
Hp complexes. Yang et al. recently re-made pigs with a premature stop codon in exon 7 of 274 
CD163, resulting in a functional CD163 knock-out, as previously reported (40). Surprisingly, 275 
this new paper claims that PBMC-derived macrophages from CD163 knock-out animals are 276 
able to uptake HbAF488-Hp complexes in vitro (23), a result that directly contradicts the 277 
findings by Schaer et al., Nielsen et al. and others (39, 41) in human macrophages, Etzerodt et 278 
al. in cells with murine CD163 (42), Boretti et al. in canine macrophages , all of which highlight 279 
the essential requirement for CD163 to be present for Hb-Hp uptake in macrophages. 280 
CD163 both in its cell-bound as well as its secreted form has been shown to have multiple 281 
other functions in addition to Hb-Hp scavenging (reviewed in (18)). One important aspect is 282 
the regulatory function of soluble CD163 following inflammation and ischemic repair, which 283 
was found to result in enhanced regeneration activity in CD163 knock-out mice resulting in 284 
abnormal peripheral blood vessel development and systemic rather than local regeneration 285 
after injury (43). Soluble CD163 is also able to bind Staphylococcus aureus, which promotes 286 
recognition, phagocytosis, and killing of this important livestock and human pathogen (44). 287 
Soluble CD163 is not the result of alternative splicing but results from proteolytic cleavage, 288 
likely by the metalloprotease ADAM17 in the juxtamembrane area following SRCR domain 9 of 289 
the protein (45). Proper folding of CD163 and accessibility of this area are essential for the 290 
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 15 
secretion of soluble CD163. Here we showed the presence of soluble CD163 in the serum of 291 
ΔSRCR5 pigs at comparable levels to wildtype animals.  292 
CD163 knock-out mice have been reported to be significantly more susceptible to intra-293 
abdominal sepsis, which is linked to haptoglobin-HMGB1 signaling and cytokine response 294 
(46). It was also found that CD163 plays a role in asthmatic human patients and CD163 knock-295 
out mice were found to have increased airway eosinophils and mucus cell metaplasia linked to 296 
CCL24 chemokine signaling upon dust mite challenge (47). We analyzed the function of 297 
ΔSRCR5 CD163 in signaling and cytokine response by measuring the base line cytokine levels 298 
of ΔSRCR5 pigs compared to their wildtype counterpart. We also monitored the cytokine 299 
levels during the course of the in vivo PRRSV challenge to identify any changes that could 300 
result from low-level PRRSV replication. Whereas we found an orchestrated sequence of 301 
inflammation and immune response signaling in the PRRSV infected wildtype animals no 302 
cytokine response was observed in the ΔSRCR5 pigs. Of the panel of 20 cytokines analyzed 303 
only one cytokine, CCL3L1, was significantly different between the two groups of animals over 304 
the entire course of the challenge. The inflammation response protein CCL3L1 is involved in 305 
inflammation response and is downregulated by IL-10 but no significant differences in IL-10 306 
between the two genotype groups could be found. We have no explanation for the higher 307 
CCL3L1 level in ΔSRCR5 pigs but the limited timeframe and animal number of this study 308 
warrant further investigation of this cytokine in the future. Another cytokine, MIG, showed 309 
higher levels in wildtype animals up to day 10 but no significant difference was observed on 310 
day 14. It will be interesting to investigate this observation further, over a longer period and 311 
with larger numbers of animals. 312 
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The creation of ΔSRCR5 pigs holds tremendous opportunity for the pork industry worldwide 313 
to improve both animal welfare and productivity at the same time. PRRSV infection has 314 
immunomodulatory outcomes and plays an important role in polymicrobial disease, such as 315 
the porcine respiratory disease complex. As such PRRSV-resistant animals could benefit 316 
general health and decrease the need for antimicrobial use at the same time. However, for the 317 
implementation of the next generation breeding / genome editing techniques in animal 318 
production, both consumer acceptance and the legislative framework need to be in place.   319 
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Materials and Methods 320 
All animal work was approved by The Roslin Institute’s and the University of Edinburgh’s 321 
Protocols and Ethics Committees as well as the ethics group at Moredun Scientific Ltd. The 322 
experiments were carried out under the authority of U.K. Home Office Project Licenses 323 
PPL60/4518, PPL60/4482, and PPL70/8827 under the regulations of the Animal (Scientific 324 
Procedures) Act 1986. Humane endpoints were clearly defined. 325 
Cells and viruses 326 
Primary pulmonary alveolar macrophages (PAMs) for the propagation of PRRSV-1, subtype 2 327 
strain BOR-57 (isolated from a sample from a Belarussian pig in 2009 by T. Stadejek et al. ) 328 
were harvested from wild type research animals aged 6–9 weeks as previously described (48). 329 
Briefly, animals were euthanized according to a schedule I method. Lungs were removed and 330 
transferred on ice to a sterile environment. Lung lavage with warm PBS and gentle massage 331 
was used to recover PAMs. Cells were collected by centrifugation for 10 min at 400 x g. When 332 
necessary red blood cells were removed using red cell lysis buffer (10 mM KHCO3, 155 mM 333 
NH4Cl, 0.1 mM EDTA, pH 8.0) for 5 min before washing again with PBS. Cells were collected by 334 
centrifugation as before and frozen in 90% FBS (HI, GE Healthcare), 10% DMSO (Sigma). Cells 335 
were frozen gradually at 1°C/min in a -80°C freezer before being transferred to -150°C.  336 
PAM cells were cultivated in RPMI-1640, Glutamax (Invitrogen), 10% FBS (HI, Gibco), 337 
100IU/ml penicillin and 100μg/ml streptomycin (Invitrogen) (RPMI +/+). 338 
Breeding and genotyping of animals 339 
Unrelated founder animals generated by zygote injection of Cas9 mRNA and sgRNAs SL26 and 340 
SL28 as described (15) were bred to each other or to wildtype animals to generate 341 
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heterozygous F1 offspring. F1 animals with a double-strand break and re-ligation without 342 
insertions or deletions at the cutting sites of SL26 and SL28 were selected for breeding the F2 343 
generation. Animals were genotyped as described previously (15), briefly, genomic DNA was 344 
extracted from ear biopsies using the DNeasy Blood and Tissue Kit (Qiagen). The region 345 
spanning intron 6 to exon 8 was amplified using primers oSL46 (ACCTTGATGATTGCGCTCTT) 346 
and oSL47 (TGTCCCAGTGAGAGTTGCAG), generating a 904 bp product from the intact allele 347 
and a 454 bp product if complete deletion of exon 7 had occurred. The PCR products were 348 
analyzed by separation on a 1% agarose gel and by Sanger sequencing.  349 
Animal challenge with BOR-57 350 
Four days prior to transfer of the animals to the specific pathogen-free unit (SPFU) blood and 351 
serum samples were taken from all animals by jugular venepuncture and the blood samples 352 
subjected to whole blood count analyses. Sera were screened using the IDEXX PRRSV X3 ELISA 353 
test to confirm that none of the animals had previously been exposed to PRRSV. Animals were 354 
acclimated in the SPFU for 1 week prior to challenge. 355 
Infectivity of BOR-57 stocks was assessed using a TCID50 assay on PAMs immediately after 356 
production, prior to challenge, and on both challenge dates after administration. BOR-57 357 
inoculum was tested for the absence of mycoplasma and other major viral pathogens. Animals 358 
were inoculated intranasally in the left nostril with 5 ml of 1E6 TCDI50/ml BOR-57 in 359 
RPMI +/+. Body weights of the animals were measured on day 0 prior to challenge, day 7 and 360 
day 14 prior to euthanasia. Serum samples were collected on day 0 prior to challenge, and 361 
days 3, 7, 10, and 14 prior to euthanasia by jugular venepuncture into vacutainer tubes. After 362 
clotting samples were centrifuged at 2000 x g for 10 min at 4°C and samples aliquoted and 363 
frozen at -80°C for further analysis. Clinical observations were recorded daily making note of 364 
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the rectal temperature, demeanor, nasal discharge, coughing and respiration. Feeding and 365 
water consumption and general health were observed and recorded daily. Humane endpoints 366 
were defined prior to challenge. No animal reached the criteria for premature termination 367 
during the challenge.  368 
Necropsy, Histopathology, & Immunohistochemistry 369 
On day 14 of the challenge animals were euthanized according to a schedule I method. During 370 
necropsy the lungs were removed, initially assessed and detailed photographs taken from the 371 
dorsal and ventral side for detailed scoring of macroscopic lung lesions. An established scoring 372 
system, based on the approximate contribution of each lung section to the complete lung 373 
volume was employed as previously described (29). Briefly, each lung lobe is assigned a 374 
number to reflect the approximate volume percentage of the entire lung represented. The 375 
affected area of each lobe is scored relative to the assigned volume percentage. Lung, 376 
mediastinal lymph node, and PAM samples were collected and frozen and lung and lymph 377 
node samples were fixed in 10% neutral-buffered formalin. Formalin-fixed sections were 378 
embedded in paraffin and routinely processed for histological examination with hematoxylin 379 
& eosin staining. Lung sections were scored for the presence and severity of interstitial 380 
pneumonia ranging from 0 (normal) to 6 (severe diffuse) as previously described (29). 381 
Immunohistochemical analysis of lung and lymph nodes for the detection of PRRSV antigen 382 
was performed as previously described (30) using a mixture of two monoclonal antibodies, 383 
SDOW-17, 1/5,000, and SR-30, 1/1,500, (both RTI) as primary antibodies. Sections were 384 
counterstained with hematoxylin.  385 
Assessment of PRRSV virus and anti-PRRSV antibody levels in serum 386 
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Viral RNA was extracted from the sera collected on day 0, 3, 7, 10, and 14 using the QIAmp 387 
Viral RNA Mini Kit (Qiagen) according to the manufacturer’s instructions. Viral RNA levels 388 
were assessed by RT-qPCR using the GoTaq 1-Step RT-qPCR system (Promega) analyzed on a 389 
LightCycler II 480 (Roche). Viral RNA extracted from PAM cell culture supernatant with 390 
known multiplicity of infection (MOI) and a custom synthesized DNA fragment (Invitrogen) 391 
with known concentration 392 
(GAGAGCGGCCGCTAATACGACTCACTATAGTCAGCTGTGTCAGCTGCTGGGAAAAATGATGAAATC393 
CCAGCGCCAGCAACCCAGGGGAGGACAGGCCAACAAAAGGAAAAAGCCTGAGAAGCCTCATTTTCCC394 
TTGGCTGCTGAAGATGACGTTCGGCACCATCTCACCGCAACTGAGCGTTCCCTCTGTCTGCAATCGAT395 
CCAGACAGCCTTCAATCAGGGTGCAGGAACTGCGTCGCTTTCACCCAGTGGGAAGGTCAGTTTTCAG396 
GTAGAGTTCATGCTGCCCCTGCAGGGAGA) were used as standards. The primers used were 397 
BOR57_FWD: GAAATCCCAGCGCCAGCAAC and BOR57_REV: TTCCCACTGGGTGAAAGCGA.  398 
Assessment of soluble CD163 serum levels 399 
Serum samples collected a week prior and on day 0 of the challenge were analyzed for the 400 
presence and level of soluble CD163. A sandwich ELISA was performed using the porcine 401 
CD163 ELISA kit (Elabscience) according to the manufacturer’s instructions and using serial 402 
dilutions of serum.  403 
Analysis of serum cytokine levels using cytokine arrays 404 
Serum samples collected on days 0 (prior to challenge), 3, 7, 10, and 14 of the challenge were 405 
analysed for the levels of 20 different cytokines. Cytokine arrays were performed using the 406 
Porcine Cytokine Antibody Array A (ab197479) and Array B (ab197480; both Abcam) 407 
according to the manufacturer’s instructions.  408 
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Figure Legends 569 
Figure 1: Generation of ΔSRCR5 pigs and experimental set-up. A) Genome editing to 570 
generate ΔSRCR5 pigs. Genome-edited founder animals were generated by zygote injection 571 
of CRISPR/Cas9 editing reagents using Cas9 mRNA and two guide RNAs, sgSL26 and sgSL28, in 572 
combination to generate a deletion of exon 7 in CD163. Animals were breed to generate F1 and 573 
F2 generations, focusing on one genotype showing clean religation at the cutting sites of both 574 
guide RNAs. Homozygous F2 animals carry this genotype in both alleles (bottom). B) 575 
Structure prediction and expression of ΔSRCR5 in pulmonary alveolar macrophages of 576 
F2 animals. Protein structure prediction using RaptorX points towards an intact protein 577 
product upon deletion of SRCR5. C) Experimental design of challenge study. 4 homozygous 578 
(green) and 4 wildtype (orange) siblings from heterozygous/heterozygous mating of the F1 579 
generation animals were co-housed from weaning. Genotypes were confirmed by PCR 580 
amplification across exon 7 (see figure 1A) and by Sanger sequencing. Piglets were co-housed 581 
after weaning and, after acclimation to the specific pathogen-free unit for 1 week and 582 
throughout the 14-day challenge experiment that was initiated by inoculating each pig 583 
intranasally with 5E6 TCID50 of the PRRSV-1, subtype 2 strain BOR-57 at day 0 & day 1 of the 584 
challenge. The piglets were 7-8 weeks of age at the start of the acclimation period. D) Piglets 1 585 
day before the start of the challenge. 586 
 587 
Figure 2: Serum levels of soluble C163. Serum samples collected 2 week prior to and on day 588 
0 of the challenge were assessed for the level of sCD163 using a commercial ELISA. n=2*2*3, 589 
displaying min/max and 90 percentile. Statistical analysis using an unpaired t-test showed no 590 
significant difference. 591 
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 592 
Figure 3: ΔSRCR5 pigs show no clinical signs or pathology of a PRRSV-1 infection. A) 593 
Rectal temperature of ΔSRCR5 (green) and wildtype piglets (orange) during the challenge with 594 
BOR-57. Rectal temperatures were measured daily during feeding. Error bars represent SEM, 595 
n=4. B) Average daily weight gain based on weight measurements at day 0, 7, and 14 of the 596 
challenge. A&B; Statistical analysis was performed using a two-way ANOVA & Sidak’s multiple 597 
comparison test. C) Viremia during the challenge with BOR-57. Serum samples were collected 598 
at day 0, 3, 7, 10, and 14 from the jugular vein using vacuum tubes, viral RNA isolated and 599 
quantified using RT-qPCR with primers specific to ORF5 of BOR-57. D) Antibody response to 600 
PRRSV-1 during the challenge. Serum samples were analyzed for the presence of PRRSV 601 
antibodies using the IDEXX PRRSV X3 ELISA test. <0.40=negative; ≧0.4=positive. Each data 602 
point / line represents a single animal; 4 animals per genotype group. E) Lung and Lymph 603 
node pathology, histopathology and immunohistochemistry scores. Lung pathology was 604 
assessed in a blind fashion and a subjective score for severity of gross lung lesions using an 605 
established scoring system was applied (scale 0-100). Lung histopathology sections were 606 
scored for the presence and severity of interstitial pneumonia ranging from 0 to 6 (0, normal; 607 
1, mild multifocal; 2, mild diffuse; 3, moderate multifocal; 4, moderate diffuse; 5, severe 608 
multifocal; 6, severe diffuse). Immunohistochemistry staining against PRRSV-N of lung and 609 
lymph node sections was scored ranging from 0-3 (0, no signal; 1, low numbers of positive 610 
cells; 2, moderate numbers of positive cells; 3, abundant). Numbers represent average 611 
n=4±SEM. F) Lung histology and immunohistochemistry. Top: formalin-fixed, paraffin-612 
embedded, haemotoxylin and eosin stained lung sections from the necropsy on day 14 post 613 
challenge. Left: ΔSRCR5, right: wildtype piglets. The scale bar represents 100 µm. Bottom: 614 
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formalin-fixed, paraffin-embedded immunohistochemical stain against PRRSV antigen 615 
(brown) and hematoxylin counterstain. Left: ΔSRCR5, right: wildtype piglets. The scale bar 616 
represents 50 µm. G) Lung pathology. Lungs from pigs at necropsy 14 days post challenge; left, 617 
lungs from two ΔSRCR5 pigs and right, lungs from two wildtype pigs. 618 
 619 
Figure 4: Cytokine response to BOR-57 PRRSV infection. Cytokine levels in serum samples 620 
collected prior to challenge on day 0, and challenge days 3, 7, 10, and 14 were measured using 621 
cytokine antibody arrays. A) Interferon α (IFNα), B) Interleukin 17A (IL-17A), C) 622 
Interleukin 1 receptor antagonist (IL-1ra), D) Interleukin 4 (IL-4), E) Interleukin 6 (IL-6), 623 
F) Interleukin 8 (IL-8), G) Monokine induced by gamma interferon (MIG/CXCL9), H) 624 
Macrophage inflammatory protein-1β (MIP-1β/CCL4), I) Chemokine ligand 3-like 1 625 
(CCL3L1),   J) Granulocyte macrophage colony-stimulating factor (GM-CSF), K) Tumor 626 
necrosis factor alpha (TNFα), L) Interleukin 12 (IL-12), M) Interleukin 1 beta (IL-1β), N) 627 
Interleukin 10 (IL-10),  O) Transforming growth factor beta 1 (TGFβ1), P) Interferon 628 
gamma (IFNγ), Q) Interleukin 18 (IL-18), R) Platelet endothelial cell adhesion molecule 629 
(PECAM-1/CD31), S) Interleukin 1 alpha (IL-1α), T) Interleukin 13 (IL-13). Error bars 630 
represent SEM, n=2*4. Statistical analysis was performed using a two-way ANOVA & Sidak’s 631 
multiple comparison test. p-values indicated are: *p≤0.5; ** p≤0.01; ***p≤0.001; ****p≤0.0001.  632 
 633 
Table 1: Whole blood count results of ΔSRCR5 (animals 4-7) & wildtype piglets at week 6 634 
(animals 8-11)  635 
 o
n
 June 25, 2018 by UNIVERSITY O
F EDINBURG
H
http://jvi.asm.org/
D
ow
nloaded from
 
 o
n
 June 25, 2018 by UNIVERSITY O
F EDINBURG
H
http://jvi.asm.org/
D
ow
nloaded from
 
 o
n
 June 25, 2018 by UNIVERSITY O
F EDINBURG
H
http://jvi.asm.org/
D
ow
nloaded from
 
 o
n
 June 25, 2018 by UNIVERSITY O
F EDINBURG
H
http://jvi.asm.org/
D
ow
nloaded from
 
 o
n
 June 25, 2018 by UNIVERSITY O
F EDINBURG
H
http://jvi.asm.org/
D
ow
nloaded from
 
Indicator 4 5 6 7 8 9 10 11 Unit 
Ref. 
Values 
WBC 22.5 24 14 15.1 12.4 19.6  26.1 14.4 x10e9/l 11-22 
Neutrophils 
(segmented) 
5.85 4.8 4.62 5.889 4.34 7.252 7.83 4.32 x10e9/l 2-15 
Neutrophils 
(segmented) 
26 20 33 39 35 37  30 30 % 20-70 
Neutrophils 
(non-segmented) 
0 0 0 0 0 0 0 0 x10e9/l 0-0.8 
Neutrophils 
(non-segmented) 
0 0 0 0 0 0  0 0 % 0-4 
Lymphocytes 15.3 18.72 8.82 8.305 7.564 11.76 16.182 9.36 x10e9/l 3.8-16.5 
Lymphocytes 68 78 63 55 61 60  62 65 % 35-75 
Monocytes 0.675 0.48 0.42 0.755 0.496 0.588 1.044 0.576 x10e9/l 0-1 
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Monocytes 3 2 3 5 4 3  4 4 % 0-10 
Eosinophils 0.675 0 0 0.151 0 0 1.044 0.144 x10e9/l 0-1.5 
Eosinophils 3 0 0 1 0 0  4 1 % 0-15 
Basophils 0 0 0.14 0 0 0 0 0 x10e9/l 0-0.5 
Basophils 0 0 1 0 0 0  0 0 % 0-3 
RBC 6.03 6.64 6.99 6.58 6.3 6.53 7.52 6.97 x10e12/l 5-9 
PCV / Hematocrit 0.384 0.391 0.383 0.388 0.382 0.39  0.429 0.421   0.36-0.43 
Hb 11.5 11.9 10.9 11.8 11.6 12 13.8 12.3 g/dl 10-16 
MCV 63.7 58.9 54.8 58.9 60.7 59.8  57.1 60.5 fL 50-62 
MCHC 29.9 30.4 28.3 30.5 30.3 30.9 32.1 29.1 g/dl 30-36 
Platelets 219 230 605 397 483 519  219 606   120-720 
RDW 20.9 23.1 28.9 20.6 21 18  17 22.6     
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